ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-02-26
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2017-03-31 was 51.79%, a 3.87% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2016-03-31 was 49.86%.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2013-03-31 was 45.41%.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 0.00%, a 100.00% decline from fiscal 2023.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 81.21%, a 9.79% decline from fiscal 2022.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 90.02%, a 57.38% increase from fiscal 2021.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 57.20%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-02-26 | |||
| 2023-12-31 | 81.21% 10-K · filed 2025-02-26 | |||
| 2022-12-31 | 90.02% 10-K · filed 2024-03-12 | |||
| 2021-12-31 | 57.20% 10-K · filed 2023-03-01 | |||
| 2017-03-31 | 51.79% 10-Q · filed 2017-05-09 | |||
| 2016-03-31 | 49.86% 10-Q · filed 2016-05-06 | |||
| 2013-03-31 | 45.41% 10-Q/A · filed 2013-08-19 | |||
| 2012-09-30 | 45.20% 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | 45.20% 10-Q · filed 2012-08-14 | |||
| 2010-12-31 | 44.81% 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |